Global HIV/AIDS Medicine

Por Lennox, Jeffrey L.
Publicado em 2008

OUTCOMES FOR CRITICALLY ILL PATIENTS WITH HIV AND SEVERE SEPSIS IN THE ERA OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

Por Greenberg, Jared A., Lennox, Jeffrey L., Martin, Greg S.
Publicado em 2011

Clinical Comparison of an Enhanced-Sensitivity Branched-DNA Assay and Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

Por Nolte, Frederick S., Boysza, Jodi, Thurmond, Cathy, Clark, W. Scott, Lennox, Jeffrey L.
Publicado em 1998

Predictors of Success with Highly Active Antiretroviral Therapy in an Antiretroviral-Naive Urban Population

Por Zaragoza-Macias, Elisa, Cosco, Dominique, Nguyen, Minh Ly, del Rio, Carlos, Lennox, Jeffrey
Publicado em 2010

Pharmacokinetics of an Indinavir-Ritonavir-Fosamprenavir Regimen in Patients with Human Immunodeficiency Virus

Por Ofotokun, Ighovwerha, Acosta, Edward P., Lennox, Jeffrey L., Pan, Yi, Easley, Kirk A.
Publicado em 2008

Liver Enzymes Elevation and Immune Reconstitution Among Treatment-Naïve HIV-Infected Patients Instituting Antiretroviral Therapy

Por OFOTOKUN, IGHOVWERHA, SMITHSON, SARAH E., LU, CHENGXING, EASLEY, KIRK A., LENNOX, JEFFREY L.
Publicado em 2007

Anti-Retroviral Therapy Is Associated with Decreased Alveolar Glutathione Levels Even in Healthy HIV-Infected Individuals

Por Cribbs, Sushma K., Guidot, David M., Martin, Greg S., Lennox, Jeffrey, Brown, Lou Ann
Publicado em 2014

Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages

Por Cribbs, Sushma K., Lennox, Jeffrey, Caliendo, Angela M., Brown, Lou Ann, Guidot, David M.
Publicado no AIDS Res Hum Retroviruses (2015)

Diversity, Divergence, and Evolution of Cell-Free Human Immunodeficiency Virus Type 1 in Vaginal Secretions and Blood of Chronically Infected Women: Associations with Immune Status

Por Sullivan, Sharon T., Mandava, Usha, Evans-Strickfaden, Tammy, Lennox, Jeffrey L., Ellerbrock, Tedd V., Hart, Clyde E.
Publicado em 2005

Lopinavir/Ritonavir Pharmacokinetic Profile: Impact of Sex and Other Covariates Following a Change From Twice-Daily to Once-Daily Therapy

Por Ofotokun, Ighovwerha, Chuck, Susan K., Binongo, Jose N., Palau, Mauricio, Lennox, Jeffrey L., Acosta, Edward P.
Publicado em 2007

Culturally-adapted and audio-technology assisted HIV/AIDS awareness and education program in rural Nigeria: a cohort study

Por Ofotokun, Ighovwerha, Binongo, Jose Nilo G, Rosenberg, Eli S, Kane, Michael, Ifland, Rick, Lennox, Jeffrey L, Easley, Kirk A
Publicado em 2010

Metabolomics of Bronchoalveolar Lavage Differentiate Healthy HIV-1-Infected Subjects from Controls

Por Cribbs, Sushma K., Park, Youngja, Guidot, David M., Martin, Greg S., Brown, Lou Ann, Lennox, Jeffrey, Jones, Dean P.
Publicado em 2014

Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment

Por Anderson, Albert M., Lennox, Jeffrey L., Nguyen, Minh L., Waldrop-Valverde, Drenna, Tyor, William R., Loring, David W.
Publicado no J Neurovirol (2016)

Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines

Por Kannanganat, Sunil, Kapogiannis, Bill G., Ibegbu, Chris, Chennareddi, Lakshmi, Goepfert, Paul, Robinson, Harriet L., Lennox, Jeffrey, Amara, Rama Rao
Publicado em 2007

Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia

Por Vardhanabhuti, Saran, Ribaudo, Heather J., Landovitz, Raphael J., Ofotokun, Ighovwerha, Lennox, Jeffrey L., Currier, Judith S., Olson, Lana M., Haas, David W.
Publicado no Open Forum Infect Dis (2015)

Integrated Population Pharmacokinetic/Viral Dynamic Modeling of Lopinavir/Ritonavir in HIV-1 Treatment Naïve Patients

Por Wang, Kun, D'Argenio, David Z., Acosta, Edward P., Sheth, Anandi N., Delille, Cecile, Lennox, Jeffrey L., Kerstner-Wood, Corenna, Ofotokun, Ighovwerha
Publicado em 2014

Immune Activation Mediated Change in Alpha-1-Acid Glycoprotein: Impact on Total and Free Lopinavir Plasma Exposure

Por Ofotokun, Ighovwerha, Lennox, Jeffrey L., Eaton, Molly E., Ritchie, James C., Easley, Kirk A., Masalovich, Svetlana E., Long, Mary C., Acosta, Edward P.
Publicado em 2011

A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Rando...

Por Ofotokun, Ighovwerha, Sheth, Anandi N., Sanford, Sara E., Easley, Kirk A., Shenvi, Neeta, White, Kelly, Eaton, Molly E., Del Rio, Carlos, Lennox, Jeffrey L.
Publicado em 2012

HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States

Por Landovitz, Raphael J., Tran, Thuy Tien T., Cohn, Susan E., Ofotokun, Ighovwhera, Godfrey, Catherine, Kuritzkes, Daniel R., Lennox, Jeffrey L., Currier, Judith S., Ribaudo, Heather J.
Publicado no AIDS Behav (2016)

HIV-1 RNA Rectal Shedding Is Reduced in Men With Low Plasma HIV-1 RNA Viral Loads and Is Not Enhanced by Sexually Transmitted Bacterial Infections of the Rectum

Por Kelley, Colleen F., Haaland, Richard E., Patel, Pragna, Evans-Strickfaden, Tammy, Farshy, Carol, Hanson, Debra, Mayer, Kenneth, Lennox, Jeffrey L., Brooks, John T., Hart, Clyde E.
Publicado em 2011